Yayınlar & Eserler

Yayın Ağı
Makaleler 20
Tümü (20)
SCI-E, SSCI, AHCI (13)
SCI-E, SSCI, AHCI, ESCI (20)
ESCI (7)
Scopus (12)
TRDizin (5)

1. Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study

Ünal Ç., Ordu Ç., Özmen T., İlgun A. S., Çelebi F., Baysal B., et al.
Current Oncology , cilt.30, sa.10, ss.9217-9229, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

2. Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey

Ünal Ç., Özmen T., Ordu Ç., Pilanci K. N., İlgün A. S., Gökmen E., et al.
Frontiers in Oncology , cilt.13, 2023 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

3. Assessment High-Risk Breast Cancer in Older Patients: A Comparative Analysis of PREDICT Scores and TAILORx Risk Categorization

Ünal Ç., Özmen T., Ordu Ç., URAS C., KARA H., Gökmen E., et al.
European Journal of Breast Health , cilt.19, sa.4, ss.325-330, 2023 (ESCI, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

4. Effect of Fear of Covid-19 Infection on Functionality in Breast Cancer Patients in the Pandemic

Cim E. F. A., Torlak E., Unveren G., Soybir G. R., Ozmen V., Iyigun Z. E., et al.
IRANIAN RED CRESCENT MEDICAL JOURNAL , cilt.24, sa.2, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier

5. LONG-TERM SURVIVAL EFFECTS OF PREOPERATIVE BREAST MRI IN PATIENTS WITH BREAST-CONSERVING SURGERY DUGOROČNI UČINAK PRIJEOPERACIJSKE MAGNETSKE REZONANCIJE NA PREŽIVLJENJE U BOLESNICA S POŠTEDNOM OPERACIJOM RAKA DOJKE

Ilgun A. S., Sarsenov D., Alco G., Ozturk A., Agacayak F., Elbuken F., et al.
Acta Clinica Croatica , cilt.61, sa.1, ss.30-37, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

6. Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience

Bahceci A., PAYDAŞ S., Ak N., Ferhatoglu F., Saip P. M., SEYDAOĞLU G., et al.
CANCER INVESTIGATION , cilt.39, sa.6-7, ss.473-481, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

7. Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment

Ibis K., Saglam S., Saglam E. K., Firat P., Yilmazbayhan D., Toker A., et al.
PATHOLOGY RESEARCH AND PRACTICE , cilt.214, sa.9, ss.1291-1296, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

8. Prognostic Significance of Adjuvant Chemotherapy Induced Amenorrhea in Luminal A and B Subtypes

Ordu C., Pilanci K. N., Alco G., Elbuken F., Koksal U. I., Ilgun S., et al.
EUROPEAN JOURNAL OF BREAST HEALTH , cilt.14, ss.173-179, 2018 (ESCI, TRDizin) Sürdürülebilir Kalkınma identifier identifier

9. Roles of Biopsychosocial Factors in the Development of Breast Cancer

Ozkan M., Yildirim N., Disci R., Ilgun A. S., Sarsenov D., Alco G., et al.
EUROPEAN JOURNAL OF BREAST HEALTH , cilt.13, ss.206-212, 2017 (ESCI, TRDizin) Sürdürülebilir Kalkınma identifier identifier

10. Attitudes of cancer patients after diagnosis: How cancer affects social life? A Turkish Oncology Group study

Nayir E., Koyuncu M. B., Esin E., Turker I., TANRIVERDİ Ö., UYSAL M., et al.
JOURNAL OF BUON , cilt.22, sa.1, ss.208-213, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

11. Receptor discordance rate and its effects on survival in primary and recurrent breast cancer patients

Ilgun S., Sarsenov D., Erdogan Z., Ordu C., Celebi F., Pilanci K. N., et al.
JOURNAL OF BUON , cilt.21, sa.6, ss.1425-1432, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

12. Chronomodulated oxaliplatin plus Capecitabine (XELOX) as a first line chemotherapy in metastatic colorectal cancer: A Phase II Brunch regimen study

PILANCI K. N., Saglam S., Okyar A., YÜCEL S., Pala-Kara Z., Ordu C., et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY , cilt.78, sa.1, ss.143-150, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

13. The Relationship between Bone Mineral Density and Estrogen Receptor Positivity in Patients with Breast Cancer

Iyigun Z. E., Pilanci K. N., Cabuk F. K., Ilgun S., Ordu C., Duymaz T., et al.
JOURNAL OF BREAST HEALTH , cilt.12, sa.3, ss.119-122, 2016 (ESCI, TRDizin) identifier

14. The Prognostic Impact of Molecular Subtypes and Very Young Age on Breast Conserving Surgery in Early Stage Breast Cancer

Ordu C., McGuire K., Alco G., Pilanci K. N., Koksal U. I., Elbuken F., et al.
CUREUS , cilt.8, sa.6, 2016 (ESCI) Sürdürülebilir Kalkınma identifier identifier

15. Current adjuvant treatment modalities for gastric cancer: From history to the future

KILIC L., Ordu C., Yildiz I., Sen F., Keskin S., Ciftci R., et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY , cilt.8, sa.5, ss.439-449, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

16. PET-MRI Findings of Two Patients with Breast Carcinoma before Treatment

Celebi F., Koksal U., Pilanci K. N., Ordu C., Sarsenov D., Ilgun S., et al.
JOURNAL OF BREAST HEALTH , cilt.12, sa.2, ss.88-90, 2016 (ESCI, TRDizin) identifier

17. True Local Recurrences after Breast Conserving Surgery have Poor Prognosis in Patients with Early Breast Cancer

Sarsenov D., Ilgun S., Ordu C., Alco G., Bozdogan A., Elbuken F., et al.
CUREUS , cilt.8, 2016 (ESCI) Sürdürülebilir Kalkınma identifier identifier

18. Adjuvant Systemic Therapy in Stage II and III Colon Cancer

Sen F., Pilanci K. N.
COLORECTAL CANCER - FROM PATHOGENESIS TO TREATMENT , ss.395-428, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

19. Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?

Pılancı K. N., Alco G., Ordu C., Sarsenov D., Celebı F., Erdogan Z., et al.
MEDICINE , cilt.94, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

20. Correlation of inflammation markers with nitrosative stress in ulcerative colitis

Atukeren P., Pilanci K. N., Kesici B., Yavuz B., Kaplan O., Erguney M.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , cilt.27, ss.168, 2012 (SCI-Expanded, Scopus) identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 2

1. Results of the Turkish prospective multi-center study utilizing the 21-gene Oncotype DX assay: Decision impact analysis.

Ozmen V., Atasoy A., Gokmen E., Ozdogan M., Guler E. N., Uras C., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) identifier

2. Chronomodulated Administration of Oxaliplatin plus Capecitabine (XELOX) as First Line Chemotherapy in Metastatic Colorectal Cancer Patients: Phase II Brunch Regimen Study.

Pilanci K. N., Saglam S., Okyar A., Yucel S., Kara Z. P., Ordu C., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) Sürdürülebilir Kalkınma identifier
Metrikler

Yayın

22

Yayın (WoS)

22

Yayın (Scopus)

12

Atıf (WoS)

63

H-İndeks (WoS)

6

Atıf (Scopus)

47

H-İndeks (Scopus)

5

Atıf (Scholar)

19

H-İndeks (Scholar)

1

Açık Erişim

5
BM Sürdürülebilir Kalkınma Amaçları